• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services
    Health Care
    Get the next $CNC alert in real time by email

    Board further strengthened with appointment of Mike McFarland as Director

    National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO.

    Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO in 2022, he has led significant financial and operational transformation at the company. Previously, he spent six years as CEO of WellCare Health Plans, during which time the company delivered superb performance in both topline and profit margin expansion, resulting in exceptional value creation prior to being acquired by Centene Corporation (NYSE:CNC). He previously held senior leadership positions at United Healthcare and Cigna Corporation. Burdick brings extensive public and private board experience. He has also devoted decades of service to non-profit organizations, including United Way, Big Brothers Big Sisters and Tampa General Hospital.

    Dr. McFarland also brings substantial public company experience, including more than 40 years in the veterinary healthcare industry. For the past 11 years, he held senior leadership roles at Zoetis, Inc., including Group Director of United States Companion Animal Marketing, Executive Vice President and Group President of the Accelerated Growth Businesses, and Executive Vice President and Chief Medical Officer. Before joining Zoetis, Mike spent 15 years in emergency medicine, including five years as the Medical Director for one of the country's first and largest after-hours emergency practices. Previously, he spent 13 years at Pfizer, Inc., serving as Group Director of CAD Veterinary Operations, Group Director of U.S. Veterinary Medical Services, and Director of Specialty Hospital Services for Pfizer Animal Health. Dr. McFarland earned his Doctor of Veterinary Medicine in 1985.

    Greg Hartmann, NVA Chairman, will remain on the Board and remains invested in the company, reinforcing his enduring confidence in NVA's strategy and profitable growth opportunities.

    "It is a privilege to welcome executives of their caliber," said Hartmann. "Ken's extensive public company and multi-site clinical experience will be a tremendous asset for NVA, our care teams and the veterinary profession. Mike brings a rare combination of clinical expertise and strategic acumen, shaped by decades of leadership in animal health, that will further strengthen our Board. I am excited to work closely with Ken, Mike, the Board and the NVA leadership team as we continue NVA's journey of value creation."

    "I am honored to lead NVA as it continues on its pathway to becoming a blue-chip veterinary care company," added Burdick. "NVA's mission, culture, and commitment to compassionate clinical excellence resonate strongly with me, and I look forward to working with the Board and leadership team as we continue to build on NVA's strong foundation to create long-term value for all stakeholders."

    "Having spent my career in animal health, I've long admired NVA's focus on quality care, community, and clinical autonomy," said McFarland. "I'm pleased to join the Board and help advance NVA's continued growth and commitment to supporting veterinary teams and the pets they serve."

    About NVA

    National Veterinary Associates Group is defining the future of pet health. NVA is a community of approximately 1,300+ premier locations across North America consisting of general practice veterinary hospitals, Ethos Veterinary Health, which consists of world-class specialty and emergency hospitals, equine hospitals and pet resorts. For more information, visit http://www.nva.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250507713573/en/

    MEDIA CONTACT:

    Michelle Reardon: Michelle.reardon@nva.com

    Get the next $CNC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC
    $LFST

    CompanyDatePrice TargetRatingAnalyst
    Centene Corporation
    $CNC
    1/5/2026$54.00Equal Weight → Overweight
    Barclays
    LifeStance Health Group Inc.
    $LFST
    12/9/2025$8.00Overweight
    Barclays
    LifeStance Health Group Inc.
    $LFST
    11/13/2025$8.00Outperform
    BMO Capital Markets
    Centene Corporation
    $CNC
    10/14/2025$33.00Sell
    Goldman
    Centene Corporation
    $CNC
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    LifeStance Health Group Inc.
    $LFST
    7/25/2025$8.00Buy
    BTIG Research
    Centene Corporation
    $CNC
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    Centene Corporation
    $CNC
    7/21/2025$33.00Buy → Hold
    TD Cowen
    More analyst ratings

    $CNC
    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief People Officer Mcnally Tanya M was granted 74,311 shares, increasing direct ownership by 131% to 131,007 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:13 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: Corporate Controller & CAO Casso Katie was granted 26,036 shares, increasing direct ownership by 30% to 113,135 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:20 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: Chief Operating Officer Smith Susan Raye was granted 112,823 shares, increasing direct ownership by 110% to 215,638 units (SEC Form 4)

    4/A - CENTENE CORP (0001071739) (Issuer)

    2/6/26 7:20:08 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

    SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 25, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3993891, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentat

    2/9/26 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Absolute Total Care receives 2025 Press Ganey Human Experience Pinnacle of Excellence Award®

    Absolute Total Care is recognized as an industry leader in Member Experience COLUMBIA, S.C., Feb. 9, 2026 /PRNewswire/ -- Absolute Total Care today announced that it has been named a 2025 Human Experience (HX) Pinnacle of Excellence Award® winner by Press Ganey, the global leader in healthcare experience solutions and services. This award is part of Press Ganey's annual ranking of the top health plans, hospitals and health systems in the country, according to performance in a variety of experience metrics. As a winner of the Press Ganey HX Pinnacle of Excellence Award®, Absolute Total Care has earned recognition for ranking in the top 5% of health plans nationwide, delivering exceptional me

    2/9/26 3:39:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    Health Net and Pro Football Hall of Fame Honor Sacramento Community and Inspire Local Youth During Super Bowl Week

    'Salute to Service' and 'Strong Youth, Strong Communities' Events Bring Pro Football Legends to Sacramento and West Sacramento SACRAMENTO, Calif., Feb. 6, 2026 /PRNewswire/ -- On Wednesday, February 4, Health Net, one of California's most experienced Medi-Cal managed care health plans and a company of Centene Corporation (NYSE:CNC), teamed up with the Pro Football Hall of Fame to celebrate the lead-up to Super Bowl Sunday with two impactful events in the Sacramento region: "Salute to Service" and "Strong Youth, Strong Communities." These annual gatherings, held near the Super Bowl host city, recognize local heroes and empower the next generation with inspiration and guidance.

    2/6/26 11:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    SEC Filings

    View All

    $CNC
    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CNC
    $LFST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CENTENE CORP (0001071739) (Filer)

    2/5/26 8:52:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.

    SCHEDULE 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    2/5/26 1:28:06 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.

    SCHEDULE 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/13/25 4:05:02 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Centene upgraded by Barclays with a new price target

    Barclays upgraded Centene from Equal Weight to Overweight and set a new price target of $54.00

    1/5/26 8:29:16 AM ET
    $CNC
    Medical Specialities
    Health Care

    Barclays initiated coverage on LifeStance Health Group with a new price target

    Barclays initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $8.00

    12/9/25 8:50:31 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on LifeStance Health Group with a new price target

    BMO Capital Markets initiated coverage of LifeStance Health Group with a rating of Outperform and set a new price target of $8.00

    11/13/25 9:14:47 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Director Burdick Kenneth A bought $498,294 worth of shares (114,181 units at $4.36), increasing direct ownership by 2% to 3,436,571 units (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    8/12/25 4:30:22 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    Leadership Updates

    Live Leadership Updates

    View All

    Sarah Personette Appointed to LifeStance Board of Directors

    Director William Miller to Step Down SCOTTSDALE, Ariz., Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced the appointment of Sarah Personette, an accomplished customer experience, media and technology executive, to the company's board of directors, effective today. William Miller, Wellsky Chairman and CEO, will step down from the board after five years of service. "Sarah's longstanding focus on understanding consumer behavior to improve the customer experience parallels our com

    8/22/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    LifeStance Names Vaughn Paunovich as Chief Technology Officer

    SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

    5/14/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $CNC
    $LFST
    Financials

    Live finance-specific insights

    View All

    LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

    SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 25, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3993891, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentat

    2/9/26 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE

    -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD

    2/6/26 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2025 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Friday, February 6, 2026, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 2815529 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under

    1/13/26 4:30:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 4:34:15 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 9:59:56 AM ET
    $LFST
    Medical/Nursing Services
    Health Care